StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
OMAXE.NS$76.86+3.20%
Fair $76.86+0.0%

OMAXE.NS

Omaxe Limited

Real Estate / Real Estate - DevelopmentNSE

$76.86

+2.38 (+3.20%)

Fairly Valued+0.0%Fair Value $76.86Fund rank 31/100 · Data gapFallback financials|
SA 26/D
F-Score: 3/9
Declining Revenue

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 77.0/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 52/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific NAV/AFFO model required: REIT/real-estate targets are disabled until FFO/AFFO/NAV/cap-rate data exists. REIT NAV/AFFO valuation requires positive AFFO/share history or TTM AFFO/share; generic FCF remains disabled. Revenue has declined for 2 consecutive years
Thesis & Journal · OMAXE.NSLocal privado en este navegador · Omaxe Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$14.1B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

77.3%

↑

Gross Margin

-40.6%

↓

Debt/Equity

-1.63

↓
52-Week Range$77
$63$113

TradingView lightweight chart

OMAXE.NS price, volumen y niveles de valoración

Último $76.86Periodo -72.4%
Fair value: $76.86

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+19.7%

FCF CAGR

-25.9%

FCF margin

14.6%

FCF / Net income

-0.26x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $12.53B · net income $-6.97B · FCF $1.82B

2023-FY → 2026-FY

Gross margin

-40.6%-21.9% pts

Operating margin

-58.3%-11.6% pts

Net margin

-55.6%-8.0% pts

FCF margin

14.6%-46.8% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$12.53B$12.53B$15.61B$15.90B$7.31B
Net Income$-6.97B$-6.97B$-6.86B$-4.03B$-3.48B
EBITDA$-6.09B$-6.09B$-5.32B$-3.48B$-2.98B
EPS-38.10-38.10-37.51-22.01-19.02
Gross Margin-40.6%-40.6%-28.8%-12.7%-18.7%
Operating Margin-58.3%-58.3%-41.3%-24.3%-46.7%
Net Margin-55.6%-55.6%-43.9%-25.3%-47.6%
Balance Sheet
Debt/Equity-1.63-1.63-3.211.411.12
Current Ratio0.970.97———
Cash Flow
Free Cash Flow$1.82B$1.82B$9.83B$9.70B$4.49B
Returns
ROE77.3%77.3%334.4%-83.8%-38.7%
Valuation
P/B———3.811.13
Growth & Yield
Revenue Growth-19.7%-19.7%-1.8%117.7%—
EPS Growth-1.6%-1.6%-70.4%-15.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -13.0%

Total return

-13.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-37.51 → -38.10

Residual

-13.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-13.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.